发明申请
US20020009449A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
失效
使用CD2 / LFA-3相互作用的抑制剂预防或治疗抗原呈递细胞驱动的皮肤状况的方法
- 专利标题： Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
- 专利标题（中）： 使用CD2 / LFA-3相互作用的抑制剂预防或治疗抗原呈递细胞驱动的皮肤状况的方法
-
申请号： US09730465申请日： 2000-12-05
-
公开(公告)号： US20020009449A1公开(公告)日： 2002-01-24
- 发明人: Barbara P. Wallner , Kevin D. Cooper
- 申请人： Biogen, Inc., a Massachusetts corporation
- 申请人地址： null
- 专利权人： Biogen, Inc., a Massachusetts corporation
- 当前专利权人： Biogen, Inc., a Massachusetts corporation
- 当前专利权人地址： null
- 主分类号： A61K039/395
- IPC分类号： A61K039/395
摘要：
Methods of using inhibitors of the CD2/LFA-3 interaction in treating skin conditions characterized by increased T cell activation and abnormal antigen presentation in the dermis and epidermis in mammals, including humans. Such conditions include psoriasis, UV damage, e.g., photoaging, atopic dermatitis, cutaneous T cell lymphoma such as mycosis fungoides, allergic and irritant contact dermatitis, lichen planus, alopecia areata, pyoderma gangrenosum, vitiligo, ocular cicatricial pemphigoid, and urticaria.
公开/授权文献
信息查询
